- Home
- / Nemaura Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Nemaura Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$8.1 K
2024-10-29
Revenue
$77 K
FY, 2023
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 503.9K | 77.0K | |||||||
| Cost of goods sold | 344.3K | 75.3K | |||||||
| Gross profit | 159.6K | (1.5M) | |||||||
| Gross profit margin, % | 31.7% | -1916.3% | |||||||
| General and administrative expense | 495.3K | 511.4K | 516.7K | 915.1K | 2.2M | 2.8M | 3.0M | 6.2M | 5.6M |
| Operating expense total | 1.3M | 1.5M | 1.6M | 1.9M | 4.5M | 4.8M | 4.6M | 7.7M | 8.1M |
| EBIT | (1.3M) | (1.5M) | (1.6M) | (1.9M) | (4.5M) | (4.8M) | (4.6M) | (7.6M) | (9.6M) |
| EBIT margin, % | -1502.3% | -12454.2% | |||||||
| Interest income | 88.5K | 23.9K | 3.9K | ||||||
| Interest expense | 2.0M | 6.7M | 6.4M | ||||||
| Pre tax profit | (1.3M) | (1.5M) | (1.6M) | (1.8M) | (4.5M) | (4.8M) | (6.6M) | (14.2M) | (14.1M) |
| Income tax expense | (614.4K) | (335.8K) | (350.3K) | ||||||
| Net Income | (1.3M) | (1.5M) | (1.6M) | (1.8M) | (4.5M) | (4.2M) | (6.3M) | (13.9M) | (14.1M) |
| EPS | (0.6) |